Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01131572 · ClinicalTrials.gov registry record · Phase 2
N-acetylcysteine in Bulimia Nervosa
A Phase 2 study, sponsored by Lindner Center of HOPE.
- Terminated
- Registry status
- Phase 2
- Development phase
- 11
- Enrollment target
NCT01131572: Clinical Trial Phase 2 study, sponsored by Lindner Center of HOPE.
NCT01131572 is a Phase 2 study that was terminated before completion, run by Lindner Center of HOPE. The registered enrollment target is 11 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01131572, a Phase 2 study, was terminated before completion, sponsored by Lindner Center of HOPE.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 11 participants
- Enrollment target
Study Summary
This study tests NAC in the treatment of Bulimia Nervosa.
Primary Outcome
The primary outcome measure will be the weekly frequency of binge-purge episodes. A binge-purge eating episode will be defined using DSM-IV-TR criteria, and accessed via clinical interview and review of subject take-home diaries at each study visit.
Interventions
- DRUG N-acetylcysteine NAC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-03 |
| Phase | Phase 2 |
Why NCT01131572 stopped before completion
NCT01131572 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which N-acetylcysteine NAC is the first listed.
NCT01131572 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01131572 about?
NCT01131572 is a clinical study titled "N-acetylcysteine in Bulimia Nervosa". This study tests NAC in the treatment of Bulimia Nervosa.
What is the current status of trial NCT01131572?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2010-02. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01131572?
The interventions under investigation include: N-acetylcysteine NAC (DRUG).
Who is sponsoring clinical trial NCT01131572?
This trial is sponsored by Lindner Center of HOPE, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01131572's enrollment target sits among peer trials
11 1967th of 2000 higher than 33 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia